Echinomycin, a Small-Molecule Inhibitor of Hypoxia-Inducible Factor-1 DNA-Binding ActivityDehe Kong, Giovanni Melillo|Cancer Research|2005Cited by 510
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapyDan P. Zandberg, Ricard Mesı́a, Antonio Jimeno et al.|European Journal of Cancer|2018Cited by 267
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibitionAnnamaria Rapisarda, Giovanni Melillo|Molecular Cancer Therapeutics|2009Cited by 170
Induction of Apoptosis in Human Cancer Cells by Candidaspongiolide, a Novel Sponge PolyketideDaniela Trisciuoglio, Giovanni Melillo|JNCI Journal of the National Cancer Institute|2008Cited by 47